shutterstock_174172250

Your Dermatologist's Free Drug Samples Aren't Really Free

By | Thu, 04/17/2014 - 10:20

Dermatologists with access to free samples are more likely to write prescriptions for higher price tag medicines when compared to their peers who do not receive free samples.

shutterstock_97598912

Smoking Weed Screws Up Students' Brains, Even If It's Just Once A Week

By | Tue, 04/15/2014 - 17:00

Marijuana use, even casually, impairs the motivational and emotional centers of students' brains.

shutterstock_186202097

Specialty Drugs Cost A Lot Of Money, So US Spending On Meds Is Soaring

By | Tue, 04/15/2014 - 13:20

A new report has revealed that 2013 saw a 3.2 percent increase in the amount Americans spent on medication, as compared to the previous year. The increasing figure is partly due to the high cost of specialty drugs.

Grastek

A New Era Of Grass Allergy Treatment: FDA Approves Grastek

By | Tue, 04/15/2014 - 12:39

The FDA's approval of Merck's Grastek ushers in a new era of grass allergy immunotherapy, as it's the second medication to be approved for grass allergies this month.

shutterstock_177290651

Should Parents Be Wary Of 'Glow Parties' Or Is This Old News?

By | Tue, 04/15/2014 - 10:55

Police warn parents that drugs such as Molly are openly being used at these electronic music and light show concerts, dubbed "glow parties."

shutterstock_181680323

There's Not Much Research On It, But Women Probably Shouldn't Take Viagra

By | Tue, 04/15/2014 - 10:00

Viagra is not designed for the female anatomy and should not be taken. There is a lack of information regarding its safety and efficacy in women.

chinese herbal medicine

Chinese Herb Shows Promise As Rheumatoid Arthritis Treatment

By | Mon, 04/14/2014 - 18:30

People have used traditional Chinese medicine for thousands of years, so it's no surprise that an herb known as the Thunder God Vine shows promise in treating rheumatoid arthritis (possibly) better than current medications.

shutterstock_139964758

Have We Cured Hepatitis C? New Treatment Has Over 90% Success Rate

By | Sat, 04/12/2014 - 01:00

A new hepatitis C treatment is safe for patients with cirrhosis who cannot take interferon. In the clinical trial, over 90 percents of patients had no hepatitis virus detected in their blood after taking the treatment for a 12-week period.

Woman smoking marijuana

Can Marijuana Allergies Lead To Food Allergies?

By | Thu, 04/10/2014 - 13:56

Do marijuana allergies actually exist? Exposure to Cannabis sativa could lead to hay fever, pink eye, skin rashes, and asthmatic symptoms, possibly increasing vulnerability to food allergies.

Tamiflu

Since Tamiflu Is (Apparently) Not Working, Here Are Some Natural Flu Remedies Instead

By | Thu, 04/10/2014 - 13:33

Flu drugs including Tamiflu and Relenza have been deemed ineffective in treating flu-like symptoms following a review by the Cochrane Collaboration.

Female doctor holding Viagra

Taking Viagra Could Lead To Deadly Skin Cancer

By | Thu, 04/10/2014 - 11:38

Warning: Men who use the erectile dysfunction treatment, Viagra, face double the risk of developing melanoma because the drug may affect the same genetic pathways that allow skin cancer to become more invasive.

Carlos López

Glass Meth Pipe Found Hidden In Florida Official’s Rectum

By | Wed, 04/09/2014 - 18:42

Police have discovered a meth pipe hidden in the rectum of a Florida official, who had been trying to conceal the object after he found he was being chased by the cops.

shutterstock_126708011

Will New Hepatitis C Guidelines From WHO Help Make Sovaldi More Affordable?

By | Wed, 04/09/2014 - 13:56

Gilead Science’s Sovaldi, a once-a-day hepatitis C drug, ushers in a new era for treatment yet many, including the World Health Organization, which has issued new guidelines for treatment of the disease, believe it is unaffordable.

shutterstock_12367624

Researchers Delve Deeper Into HPV-Related Head-And-Neck Cancers

By | Tue, 04/08/2014 - 16:00

A new study has identified four proteins that play a crucial role in drug-resistant HPV-negative head-and-neck squamous cell cancers, bringing hope to researchers seeking better drug targets.

shutterstock_148681031

FDA To Expedite Review On 'Breakthrough' Menengitis B Vaccine

By | Mon, 04/07/2014 - 10:39

Novartis said that its meningitis B vaccine, Bexsero, received "breakthrough therapy" status from the FDA, which already permitted its use in the past few months at Princeton and UC Santa Barbara following meningitis B outbreaks.

Pages